Cargando…

Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients

Proprotein convertase subtilisin/kexin 9 (PCSK9) plays an important role in lipid metabolism while available literature regarding its involvement in the pathogenesis of atherosclerosis and in the expression of genes associated with apoptosis and inflammation is constantly increasing. Patients with c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dounousi, Evangelia, Tellis, Constantinos, Pavlakou, Paraskevi, Duni, Anila, Liakopoulos, Vasillios, Mark, Patrick B., Papagianni, Aikaterini, Tselepis, Alexandros D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318757/ https://www.ncbi.nlm.nih.gov/pubmed/34336112 http://dx.doi.org/10.1155/2021/6677012

Ejemplares similares

PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation
por: Dafnis, Ioannis, et al.
Publicado: (2022)

Survival of Peritoneal Membrane Function on Biocompatible Dialysis Solutions in a Peritoneal Dialysis Cohort Assessed by a Novel Test
por: Balafa, Olga, et al.
Publicado: (2021)

Editorial for the Special Issue “Vitamin K in Chronic Disease and Human Health”
por: Dounousi, Evangelia, et al.
Publicado: (2022)

The Endothelial Glycocalyx as a Target of Ischemia and Reperfusion Injury in Kidney Transplantation—Where Have We Gone So Far?
por: Duni, Anila, et al.
Publicado: (2021)

Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?
por: Duni, Anila, et al.
Publicado: (2017)

Oxidative Stress and Acute Kidney Injury in Critical Illness: Pathophysiologic Mechanisms—Biomarkers—Interventions, and Future Perspectives
por: Pavlakou, Paraskevi, et al.
Publicado: (2017)

Oxidative Stress and the Kidney in the Space Environment
por: Pavlakou, Paraskevi, et al.
Publicado: (2018)

Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne’s Thread
por: Duni, Anila, et al.
Publicado: (2019)

Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet?
por: Roumeliotis, Stefanos, et al.
Publicado: (2022)

In vitro Investigation of Platelet Dysfunction Induced by Osmotic Pressure Variations
por: Pantazi, Despoina, et al.
Publicado: (2023)

Acute Kidney Transplant Rejection After Administration of Nivolumab in a Dialysis Patient With a Failed Graft
por: Duni, Anila, et al.
Publicado: (2021)

Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study
por: Ioannou, Kyriakos, et al.
Publicado: (2015)

Editorial: Nutrition Management for Chronic Kidney Disease
por: Liakopoulos, Vassilios, et al.
Publicado: (2020)

PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction
por: Sun, Hua, et al.
Publicado: (2018)

The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F(2a) levels
por: Rizos, Christos V., et al.
Publicado: (2013)

Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity – the effect of vitamin D supplementation: a pilot study
por: Makariou, Stefania E., et al.
Publicado: (2020)

The Association of Circulating CD14++CD16+ Monocytes, Natural Killer Cells and Regulatory T Cells Subpopulations With Phenotypes of Cardiovascular Disease in a Cohort of Peritoneal Dialysis Patients
por: Duni, Anila, et al.
Publicado: (2021)

Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State
por: Gatsiou, Aikaterini, et al.
Publicado: (2021)

Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease
por: Duni, Anila, et al.
Publicado: (2023)

PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
por: Zulkapli, Rahayu, et al.
Publicado: (2023)

Resistant Hypertension in Nondialysis Chronic Kidney Disease
por: Borrelli, Silvio, et al.
Publicado: (2013)

Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review
por: Roumeliotis, Stefanos, et al.
Publicado: (2019)

Redox Systems Biology in Chronic Kidney Disease
por: Roumeliotis, Stefanos, et al.
Publicado: (2023)

Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen
por: Tsiailanis, Antonios D., et al.
Publicado: (2023)

Oxidative Stress in End-Stage Renal Disease: Pathophysiology and Potential Interventions
por: Roumeliotis, Stefanos, et al.
Publicado: (2023)

The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
por: Keeter, William Coles, et al.
Publicado: (2022)

The Humoral Immune Response to BNT162b2 Vaccine Is Associated With Circulating CD19+ B Lymphocytes and the Naïve CD45RA to Memory CD45RO CD4+ T Helper Cells Ratio in Hemodialysis Patients and Kidney Transplant Recipients
por: Duni, Anila, et al.
Publicado: (2021)

PCSK9 attenuates efferocytosis in endothelial cells and promotes vascular aging
por: Liu, Shijie, et al.
Publicado: (2023)

Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?
por: Liakopoulos, Vassilios, et al.
Publicado: (2019)

Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review
por: Roumeliotis, Stefanos, et al.
Publicado: (2019)

Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Safety and Tolerability of PCSK9 Inhibitors: Current Insights
por: Kosmas, Constantine E, et al.
Publicado: (2020)

Home-Based Exercise Training and Cardiac Autonomic Neuropathy in Kidney Transplant Recipients with Type-II Diabetes Mellitus
por: Michou, Vassiliki, et al.
Publicado: (2023)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2018)

Oxidative Stress in Hemodialysis Patients: A Review of the Literature
por: Liakopoulos, Vassilios, et al.
Publicado: (2017)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7ul5uack9pq8rhkpi9cm68j3rs